Vanguard PRIMECAP Inv (VPMCX)
177.00
+0.74 (+0.42%)
USD |
Oct 21 2021
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.38% | 73.94B | 0.87% | 6.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -8.219B | 33.58% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VPMCX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Theo Kolokotrones | 36.36 yrs |
| Joel Fried | 32.77 yrs |
| Alfred Mordecai | 21.77 yrs |
| M. Ansari | 13.76 yrs |
| James Marchetti | 6.68 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
99
-8.219B
-27.26B
Category Low
28.38B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of September 30, 2021
Performance Versus Category
As of October 21, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of October 21, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Eli Lilly and Co | 5.77% | 243.88 | 1.12% |
| Biogen Inc | 4.22% | 264.81 | -2.00% |
| Microsoft Corp | 4.18% | 309.08 | -0.54% |
| Adobe Inc | 3.93% | 643.77 | 0.80% |
| FedEx Corp | 3.57% | 233.04 | 0.09% |
| Texas Instruments Inc | 3.25% | 199.06 | -1.11% |
| Amgen Inc | 3.07% | 209.25 | 0.12% |
| Micron Technology Inc | 2.91% | 67.51 | -1.65% |
| Alibaba Group Holding Ltd ADR | 2.70% | 177.77 | 0.20% |
| Alphabet Inc Class A | 2.39% | 2751.59 | -3.04% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | Upgrade |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| The investment seeks long-term capital appreciation. The fund invests in stocks considered to have above-average earnings growth potential that is not reflected in their current market prices. Its portfolio consists predominantly of large- and mid-capitalization stocks. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | VPMCX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Blend |
| Category Index | Russell 1000 TR USD |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Vanguard |
| Prospectus Benchmark Index | |
| S&P 500 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Theo Kolokotrones | 36.36 yrs |
| Joel Fried | 32.77 yrs |
| Alfred Mordecai | 21.77 yrs |
| M. Ansari | 13.76 yrs |
| James Marchetti | 6.68 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (10-21-21) | 0.87% |
| 30-Day SEC Yield (10-15-21) | Upgrade |
| 7-Day SEC Yield (11-28-03) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 24.88 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of June 30, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 11/1/1984 |
| Last Annual Report Date | 9/30/2020 |
| Last Prospectus Date | 1/31/2021 |
| Share Classes | |
| VPMAX | Inst |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |